eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | myeloperoxidase deficiency |
| Comorbidity | C0024437|macular degeneration |
| Sentences | 4 |
| PubMedID- 23312760 | Conclusion: xanthophyll supplementation significantly increased serum concentrations and mpod in patients with early age-related macular degeneration, and a higher lutein supplementation (20 mg/d) might be more effective in increasing these two biochemical markers in chinese patients without significant side effects. |
| PubMedID- 26100452 | Introduction: the purpose of this study was to determine macular pigment optical density (mpod) in patients with macular degeneration as well as in patients with non-proliferative diabetic retinopathy. |
| PubMedID- 23434908 | We studied the macular pigment ocular density (mpod) in patients with early age macular degeneration (amd) before and 1 year after nutritional supplementation with lutein and docosahexaenoic acid (dha). |
| PubMedID- 23695657 | Background: the primary objective of lutega is to determine the long-term effect of a supplementation with fixed combination of lutein, zeaxanthin, omega-3-longchain-polyunsaturated-fatty-acids (o-3-lcpufas) and antioxidants on macular pigment optical density (mpod) in patients with non-exudative age-related macular degeneration (amd). |
Page: 1